Can Shingles Recur After Recovery?

Herpes zoster—commonly known as shingles—is caused by the reactivation of the latent varicella-zoster virus (VZV), the same pathogen responsible for chickenpox. After primary infection, VZV establishes lifelong latency in dorsal root ganglia or cranial nerve ganglia. While most individuals experience only a single episode of shingles, recurrence is possible—and well-documented in clinical literature.

Population-based studies indicate that the overall risk of shingles recurrence ranges from approximately 5% to 10% over a 7- to 10-year follow-up period. Recurrence is more likely in immunocompromised individuals—including those with hematologic malignancies, HIV infection, solid organ transplants, or those receiving immunosuppressive biologics or high-dose corticosteroids. Age also plays a role: older adults, particularly those over 60, face higher recurrence rates due to immunosenescence and declining VZV-specific T-cell immunity.

Importantly, recurrence does not necessarily imply treatment failure or inadequate antiviral therapy during the initial episode. Rather, it reflects the complex interplay between viral latency, host immune surveillance, and environmental or physiological stressors—such as acute illness, psychological stress, or trauma—that may transiently impair cell-mediated immunity.

Vaccination significantly modifies recurrence risk. The recombinant zoster vaccine (RZV), administered in two doses, demonstrates over 90% efficacy in preventing both primary shingles and recurrent episodes—even among individuals with a prior history of the disease. In contrast, the live attenuated zoster vaccine (ZVL) offers lower and less durable protection, especially in older or immunocompromised populations, and is no longer recommended in many countries.

Clinicians should counsel patients with a history of shingles about modifiable risk factors—including optimizing immunocompetence through chronic disease management, avoiding unnecessary immunosuppression, and timely vaccination with RZV. For patients experiencing suspected recurrence, prompt clinical evaluation is essential to confirm diagnosis and rule out alternative dermatologic or neurologic conditions that may mimic shingles.